This session provides a focused overview of hallucinogen use and related disorders in addiction medicine, including key concepts in epidemiology, classification, and pharmacology of psychedelics and other hallucinogenic substances, aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas.
What This Covers • Epidemiology, classification, and pharmacology of psychedelics and other hallucinogenic substances • Patterns of use across a range of hallucinogens • Clinical presentations associated with hallucinogen use, including intoxication and persistent perceptual changes • Hallucinogen-induced psychiatric conditions and related diagnostic considerations • Evaluation of risks and clinical challenges associated with hallucinogen use • Emerging evidence regarding the potential therapeutic use of psychedelics in substance use disorders • Application of clinical frameworks to assess both risks and therapeutic potential in practice
How This Resource Is Used This session is designed for on-demand learning and targeted content review. It can be used to reinforce specific knowledge areas or as part of structured board preparation.
Joji Suzuki, MD
Dr. Suzuki is Director of the Division of Addiction Psychiatry at Brigham and Women’s Hospital and Program Director of the Addiction Medicine Fellowship. He is an Assistant Professor of Psychiatry at Harvard Medical School.
His work focuses on addiction psychiatry, substance use disorders, and medical psychiatry, with an emphasis on clinical research and medical education. He has received federal research funding and has published extensively in addiction and psychiatric care.
To support a meaningful learning experience and recognize your participation:
Access PeriodAccess to this recording is available through June 30, 2027, in alignment with ACAAM’s annual academic cycle.
Recording Release CycleACAAM releases updated recorded sessions each July based on the prior academic year’s didactic series. These recordings are available for a limited time and are retired on June 30 of the following year as new content is released.